These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 17352214)

  • 1. Stathmin is overexpressed in malignant mesothelioma.
    Kim JY; Harvard C; You L; Xu Z; Kuchenbecker K; Baehner R; Jablons D
    Anticancer Res; 2007; 27(1A):39-44. PubMed ID: 17352214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated leukocyte cell-adhesion molecule (ALCAM) promotes malignant phenotypes of malignant mesothelioma.
    Ishiguro F; Murakami H; Mizuno T; Fujii M; Kondo Y; Usami N; Yokoi K; Osada H; Sekido Y
    J Thorac Oncol; 2012 May; 7(5):890-9. PubMed ID: 22722789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stathmin as a marker for malignancy in pheochromocytomas.
    Björklund P; Cupisti K; Fryknäs M; Isaksson A; Willenberg HS; Akerström G; Hellman P; Westin G
    Exp Clin Endocrinol Diabetes; 2010 Jan; 118(1):27-30. PubMed ID: 19449284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiling of malignant mesothelioma.
    Singhal S; Wiewrodt R; Malden LD; Amin KM; Matzie K; Friedberg J; Kucharczuk JC; Litzky LA; Johnson SW; Kaiser LR; Albelda SM
    Clin Cancer Res; 2003 Aug; 9(8):3080-97. PubMed ID: 12912960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microdissection, mRNA amplification and microarray: a study of pleural mesothelial and malignant mesothelioma cells.
    Mohr S; Bottin MC; Lannes B; Neuville A; Bellocq JP; Keith G; Rihn BH
    Biochimie; 2004 Jan; 86(1):13-9. PubMed ID: 14987796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiling of malignant mesothelioma cell lines: cDNA array study.
    Kettunen E; Nissén AM; Ollikainen T; Taavitsainen M; Tapper J; Mattson K; Linnainmaa K; Knuutila S; El-Rifai W
    Int J Cancer; 2001 Feb; 91(4):492-6. PubMed ID: 11251971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel candidate oncogenes and tumor suppressors in malignant pleural mesothelioma using large-scale transcriptional profiling.
    Gordon GJ; Rockwell GN; Jensen RV; Rheinwald JG; Glickman JN; Aronson JP; Pottorf BJ; Nitz MD; Richards WG; Sugarbaker DJ; Bueno R
    Am J Pathol; 2005 Jun; 166(6):1827-40. PubMed ID: 15920167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of stathmin in oral squamous-cell carcinoma: correlation with tumour progression and poor prognosis.
    Kouzu Y; Uzawa K; Koike H; Saito K; Nakashima D; Higo M; Endo Y; Kasamatsu A; Shiiba M; Bukawa H; Yokoe H; Tanzawa H
    Br J Cancer; 2006 Mar; 94(5):717-23. PubMed ID: 16495930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of stathmin in asbestos-like fibers-induced mesothelioma: A preliminary report.
    Lombardo C; Broggi G; Vitale E; Ledda C; Loreto C; Matera S; Hagnas M; Caltabiano R; Filetti V
    Histol Histopathol; 2023 Nov; 38(11):1249-1256. PubMed ID: 37466108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential gene expression in mesothelioma.
    Rihn BH; Mohr S; McDowell SA; Binet S; Loubinoux J; Galateau F; Keith G; Leikauf GD
    FEBS Lett; 2000 Sep; 480(2-3):95-100. PubMed ID: 11034307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of stathmin-mediated microtubule destabilization sensitizes retinoblastoma cells to a low dose of antimicrotubule agents: a novel synergistic therapeutic intervention.
    Mitra M; Kandalam M; Sundaram CS; Verma RS; Maheswari UK; Swaminathan S; Krishnakumar S
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5441-8. PubMed ID: 21546534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of hyaluronan synthases and hyaluronan in malignant mesothelioma cells.
    Liu Z; Dobra K; Hauzenberger D; Klominek J
    Anticancer Res; 2004; 24(2B):599-603. PubMed ID: 15161000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coordinated expression of stathmin family members by far upstream sequence element-binding protein-1 increases motility in non-small cell lung cancer.
    Singer S; Malz M; Herpel E; Warth A; Bissinger M; Keith M; Muley T; Meister M; Hoffmann H; Penzel R; Gdynia G; Ehemann V; Schnabel PA; Kuner R; Huber P; Schirmacher P; Breuhahn K
    Cancer Res; 2009 Mar; 69(6):2234-43. PubMed ID: 19258502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of calretinin and the alternatively spliced form calretinin-22k in primary pleural mesotheliomas and in their metastases.
    Schwaller B; Celio MR; Doglioni C
    Anticancer Res; 2004; 24(6):4003-9. PubMed ID: 15736446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profiles in mouse embryo fibroblasts lacking stathmin, a microtubule regulatory protein, reveal changes in the expression of genes contributing to cell motility.
    Ringhoff DN; Cassimeris L
    BMC Genomics; 2009 Jul; 10():343. PubMed ID: 19643027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of intelectin overexpression in malignant pleural mesothelioma by serial analysis of gene expression (SAGE).
    Wali A; Morin PJ; Hough CD; Lonardo F; Seya T; Carbone M; Pass HI
    Lung Cancer; 2005 Apr; 48(1):19-29. PubMed ID: 15777968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L1CAM, INP10, P-cadherin, tPA and ITGB4 over-expression in malignant pleural mesotheliomas revealed by combined use of cDNA and tissue microarray.
    Kettunen E; Nicholson AG; Nagy B; Wikman H; Seppänen JK; Stjernvall T; Ollikainen T; Kinnula V; Nordling S; Hollmén J; Anttila S; Knuutila S
    Carcinogenesis; 2005 Jan; 26(1):17-25. PubMed ID: 15447976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stathmin 1 is a potential novel oncogene in melanoma.
    Chen J; Abi-Daoud M; Wang A; Yang X; Zhang X; Feilotter HE; Tron VA
    Oncogene; 2013 Mar; 32(10):1330-7. PubMed ID: 22665054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 1p-encoded protein stathmin and resistance of malignant gliomas to nitrosoureas.
    Ngo TT; Peng T; Liang XJ; Akeju O; Pastorino S; Zhang W; Kotliarov Y; Zenklusen JC; Fine HA; Maric D; Wen PY; De Girolami U; Black PM; Wu WW; Shen RF; Jeffries NO; Kang DW; Park JK
    J Natl Cancer Inst; 2007 Apr; 99(8):639-52. PubMed ID: 17440165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stathmin overexpression cooperates with p53 mutation and osteopontin overexpression, and is associated with tumour progression, early recurrence, and poor prognosis in hepatocellular carcinoma.
    Yuan RH; Jeng YM; Chen HL; Lai PL; Pan HW; Hsieh FJ; Lin CY; Lee PH; Hsu HC
    J Pathol; 2006 Aug; 209(4):549-58. PubMed ID: 16739096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.